Merial is a world-leading animal healthcare company with a global market share of more than 14 percent.
An innovation-driven leader, Merial makes significant investments in research and development, with ten research and development centers around the world. Merial is committed to developing pharmaceuticals and vaccines with the highest level of quality, safety and efficacy through an extensive network of 16 manufacturing sites.
Merial provides a comprehensive range of products to enhance the health, well-being and performance of a wide range of animals. We play a pioneering role with governments around the globe to contain and manage various animal diseases—recognizing that the prevention and treatment of animal diseases are in the interests of protecting the health of animals and of man.
Merial is a world-leading, innovation-driven animal health company, providing a comprehensive range of products to enhance the health, well-being and performance of a wide range of animals. Merial employs approximately 5600 people and operates in more than 150 countries worldwide. Its 2010 sales were over $2.6 billion. Merial is the animal health division of sanofi-aventis.